Regenerative medicine company Orthocell closes oversubscribed IPO Orthocell raises $8 million from investors Funds to be used to increase marketing of Orthocell's therapies as well as maintaining and preparing for regulatory approval its products in Australia and overseas Perth, Australia; 22 July 2014: Commercial-stage regenerative medicine ... (more)
http://ift.tt/1wWoHep
http://ift.tt/1wWoHep
No comments:
Post a Comment